• Home
  1. Home
  2. Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab
Scientific article
OA Policy
English

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab

Contributors

Burmester, Gerd R; Kaeley, Gurjit S; Kavanaugh, Arthur F; Gabay, Cem; MacCarter, Daryl K; Nash, Peter; Takeuchi, Tsutomu; Goss, Sandra L; Rodila, Ramona; Chen, Kun; Kupper, Hartmut; Kalabic, Jasmina

Published in

RMD Open, vol. 3, no. 2, e000465

Publication date

2017

Abstract

Treatment of rheumatoid arthritis (RA) with a combination of methotrexate (MTX)+adalimumab (ADA) is more effective than ADA monotherapy. We assessed the toxicity of different doses of MTX and treatment efficacy of ADA+MTX in two trials.

UNIGE affiliation entities

UNIGE research groups

Citation (ISO format)

BURMESTER, Gerd R et al. Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab. In: RMD Open, 2017, vol. 3, n° 2, p. e000465. doi: 10.1136/rmdopen-2017-000465

Main files (1)

Article (Published version)
CC BY-NC

Identifiers

Journal ISSN

2056-5933
404views
386downloads

Technical informations

Creation

03/09/2018 11:18:00

First validation

03/09/2018 11:18:00

Update

24/01/2025 14:27:57

Status update

24/01/2025 14:27:57

Last indexation

24/01/2025 14:36:22
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated